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ABSTRACT  
Objectives: To investigate rates of acute epididymitis diagnosed in Australian hospital settings. 
Methods: Yearly hospital admission and emergency department (ED) rates of epididymitis as 
primary diagnosis were calculated for 15-44 year old men for three states (Victoria, New South 
Wales, Queensland) from 2009 to 2014 using population denominators. Zero inflated poisson 
regression models were used to analyse variation in rates by year, age, and residential area.  
Additionally, we investigated national epididymitis admission trends from 2009 to 2018 using 
generalised linear models.  
Results: Between 2009 and 2014 there was a total of 7375 admissions and 17281 ED presentations 
for which epididymitis was the main reason for care. Most epididymitis diagnoses (94.0% in 
admissions, 99.7% in EDs) were without abscess, and 2.5% of admissions were for chlamydial 
epididymitis. Almost a quarter (23.3%) of epididymitis diagnosed in EDs resulted in hospital 
admission. In 2014, the epididymitis rate per 100 000 men was 38.7 in admissions and 91.9 in EDs. 
Comparing 2014 with 2009, the overall epididymitis diagnosis rate increased in admissions by 32% 
(adjusted incident rate ratio (aIRR) 1.32, 95%CI 1.20 to 1.45) and in ED attendances by 40% (aIRR 
1.40, 95%CI 1.31 to 1.49).  By age, the highest rates were among men 35-44 years in admissions 
and men 15-24 years in EDs. National admission rates of epididymitis during 2009-2018 showed a 
similar pattern.  
Conclusion: Rates of epididymitis diagnosis in hospital admission and ED presentations increased. 
Different age-related rates in these settings suggest a different aetiology or differential severity by 
age group.  
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BACKGROUND 
Acute epididymitis is an inflammation (usually unilateral) caused by infection of the epididymis 
that can also affect the adjacent testicle and cause epididymo-orchitis.(1, 2) Typical symptoms 
include recent onset pain and swelling.  The sexually transmissible infections (STIs) Chlamydia 
trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhoea) are often implicated for men 
aged <35 years. Other causes of acute epididymitis include enteric pathogens (e.g. Escherichia 
coli) transmitted via insertive anal intercourse or urinary tract pathogens that are common for 
older men.(1, 2)  
Over recent years, Australia, like many high-income countries has experienced increasing STI 
rates. For males, diagnosis rates per 100,000 population of chlamydia increased from 231 to 395 
and gonorrhoea from 47 to 174 between 2009 and 2017.(3) While testing is likely to contribute 
to such increases, surveillance data suggest increasing chlamydia and gonorrhoea incidence in 
heterosexual and men who have sex with men.(4) In this context epididymitis rates could 
change; potentially rising with increasing STI transmission or declining with extra testing that 
detects STIs before progression to complications. Australian epididymitis rates are largely 
unknown. Where reported, epididymitis rates remained constant in hospital admissions (1992-
2001)(5) and general practice clinics (1998-2003).(6)  
We previously reported on female STI-related morbidity in Australia(7) and here provide 
updated yearly epididymitis rates in Australian hospitals.   
METHODS 
We undertook an ecological study using hospital admission and emergency department (ED) 
data for epididymitis in the three most populous Australian states [Victoria, New South Wales 
(NSW) and Queensland].  These data were obtained for the years 2009 to 2014 for purposes of 
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analysing  a chlamydia testing intervention trial(8) we now apply the same methods as described 
in our study of female STI-associated morbidity.(7) We obtained non-identifiable, line-listed 
records from State-specific hospital admission and ED datasets for all 15-44-year-old patients 
with a main epididymitis diagnosis. Hospital admissions datasets included data for all hospitals 
in the state. ED datasets included data for presentations to public (government-funded) hospitals 
with a designated ED. Data reporting from EDs was voluntary; therefore as in our earlier 
study(7) we only included records from hospitals contributing data in all study years and  if the 
yearly number of ED presentations varied by <50% and >75% records had a principal diagnosis 
coded.  Admissions and ED data items included year, age group, residential postcode and 
principal diagnosis code. Records with an International Classification of Diseases 10th Revision 
(ICD-10) of N45, N45.9, A56.1 or A54.2, or, concordant ICD-9 or Systematized Nomenclature 
of Medicine code were classified as epididymitis.  Denominator data at postcode level comprised 
the annual male estimated residential population (ERP). Based on standard definitions, we 
classified 1678 postcodes for remoteness and socio-economic status (SES). We prepared two 
datasets comprising a) all admissions and b) all ED attendances with a principal epididymitis 
diagnosis and population per postcode. 
Additionally, to provide more recent and national rates, for men aged 15-44 we obtained the 
annual ERP, and, aggregated yearly hospital separations data with a primary epididymitis 
diagnosis for all Australia during 2009-2018. ED data nationally were not publicly available for 
this period.  
Data were analysed using Stata 16 (StataCorp, College Station, Texas, USA).  We examined 
variation in rates by year, age-group, remoteness and SES using univariable and multivariable 
zero-inflated poisson regression models. We included residential area measures to assess whether 
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rates differed between areas of different affluence or remoteness. Using likelihood ratio tests, we 
investigated interactions between residential area and age-group and reported them if statistically 
and clinically meaningful. National trends in epididymitis admission rates were examined using 
generalised linear models. We report incidence rate ratios (IRR) with 95% confidence intervals 
(95% CI). 
The Royal Australian College of General Practitioners National Research and Evaluation Ethics 
Committee approved the study (NREEC09.019). 
RESULTS 
Between 2009 and 2014 across Victoria, NSW and Queensland, epididymitis was the main 
diagnosis in 7375 admissions (94.0% without abscess, 3.3% with abscess, 2.5% with chlamydia, 
0.2% with gonorrhea) and 17281 ED presentations (99.7% without abscess) (Supplementary 
table 1).  In EDs, 23.3% of epididymitis diagnoses resulted in hospital admission (20.4%, 
95%CI18.8-22.1 in 2009; 28.4%, 95%CI 26.9-29.9 in 2014). Epididymitis diagnosis rates per 
100,000 men increased between 2009 and 2014; in admissions from 28.3 to 38.7 and EDs from 
64.8 to 91.9 (Figure 1A).  In multivariable analysis (Table 1) the overall epididymitis rate was 
higher in 2014 than 2009 in admissions (aIRR 1.32, 95%CI 1.20-1.45) and EDs (aIRR 1.40, 
95%CI 1.31-1.49). Men 35-44 years experienced the highest admission rates. ED rates were 
highest for men 15-24 years.  
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Table 1: Number of epididymitis cases and factors associated with epididymitis rates in Australian hospitals (Victoria, NSW, 
Queensland), 2009-2014* 
 Admission Emergency Department  
Cases  Univariable Multivariable  Cases  Univariable Multivariable   
n  IRR (95% CI) aIRR (95% CI) n  IRR (95% CI) aIRR (95% CI) 
Overall 7375     17281   
Age group in years         
15-24  2208  0.83 (0.78-0.89) 0.82 (0.77-0.87) 6205 1.20 (1.14-1.25) 1.18 (1.13-1.23) 
25-34 2510 0.91 (0.86-0.97) 0.91 (0.85-0.97) 5915 1.10 (1.05-1.15) 1.10 (1.05-1.15) 
35-44 2657 1.0  1.0  5161 1.0 1.0 
Area of residence         
Metropolitan 5429  1.0  1.0  12101 1.0 1.0 
Inner regional 1331 1.11 (1.01-1.21) 1.04 (0.95-1.13) 3748 1.38 (1.30-1.47) 1.30 (1.22-1.37) 
Outer regional/remote 615 1.18 (0.99-1.39) 1.10 (0.93-1.30) 1432 1.43 (1.30-1.58) 1.35 (1.22-1.49) 
SES         
Deciles of increasing disadvantage  1.06 (1.05-1.07) 1.06 (1.05-1.07)  1.06 (1.05-1.06) 1.05 (1.04-1.05) 
Year         
2009 1014  1.0  1.0  2323 1.0 1.0 
2010 1143 1.11 (1.00-1.22) 1.10 (1.00-1.21) 2393 1.02 (0.95-1.09) 1.02 (0.96-1.10) 
2011 1247 1.20 (1.09-1.32) 1.19 (1.08-1.31) 2719 1.14 (1.07-1.22) 1.14 (1.07-1.22) 
2012 1259 1.18 (1.07-1.30) 1.17 (1.07-1.29) 3065 1.25 (1.17-1.33) 1.26 (1.18-1.35) 
2013 1251 1.16 (1.05-1.27) 1.16 (1.06-1.27) 3314 1.36 (1.27-1.46) 1.37 (1.28-1.46) 
2014 1461 1.32 (1.21-1.45) 1.32 (1.20-1.44) 3467 1.38 (1.29-1.47) 1.40 (1.31-1.49) 
*Zero inflated poisson regression models 
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Nationally across Australia between 2009 and 2018, epididymitis was the main diagnosis in 
17299 hospital admissions. During the 2009-2014 period of our state-based analysis there were 
9459 epididymitis admissions nationally of which 78% were across Victoria, NSW and 
Queensland and the corresponding population for the three states was 77% of the national ERP. 
Nationally, the epididymitis admission rate per 100,000 men increased by 3% yearly from 30.9 
in 2009 to 38.5 in 2018 (Figure 1B) (IRR 1.03, 95%CI 1.03-1.04, p<0.01) and increased across 
all age groups.   
DISCUSSION 
This study found for men aged 15-44 years that epididymitis diagnosis rates in hospital 
admissions and ED attendances in the three most populous Australian states increased by up to 
40% between 2009 and 2014.  Epididymitis was managed more frequently in ED, where rates 
were up to 2.5 times those in admissions. Admission rates were highest for older men. ED rates 
were highest for younger men and in non-metropolitan areas.  We found a similar pattern for 
epididymitis admission rates nationally.   
This study applied the same methodology used in our analysis of female STI-related 
morbidity,(7) therefore, we consider the strengths and limitations to be similar. Notably, this 
study was strengthened by including ED data to provide new knowledge about epididymitis in 
Australia.  Further, our analysis at postcode level allowed comparison of population rates 
between areas with different socio-economic characteristics. An important limitation was this 
study only considered epididymitis managed in hospitals.  An Australian study estimated that 
14,700 general practice consultations for epididymitis among men aged 15-34  occurred annually 
during 1998-2003.(6) Primary care data are needed for a more complete picture, but are not 
routinely available. Further, our ED data did not represent all ED presentations for epididymitis 
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within the three states. We minimised variability in ED rates by restricting our analysis to EDs 
providing data for all study years and with high completeness.  
Only a handful of studies have investigated epididymitis trends and few if any in the last decade.  
We found for men aged 15-44 that national epididymitis admission rates per 100,000 increased 
from 31 in 2009 to 39 in 2018.  This contrasts with unchanging admission rates reported for 
same aged men in Australia (1992-2001) (~35 per 100,000 in 2001) (5) and New Zealand (1998-
2008) (~45 per 100,000 in 2008).(9) Our ED rates showed a similar pattern to our admission 
rates, increasing by 40% during 2009-2014, although overall ED rates were substantially higher 
than admission rates.  We also found that 23% of epididymitis diagnoses in ED were admitted to 
hospital. This is substantially higher than for Australian general practice during 1998-2003 when 
<2% epididymitis consultations resulted in hospital referral; although 72% of these encounters 
were for men >35 years.(6)  In the United Kingdom, a comprehensive analysis of general 
practice data reported declining epididymitis incidence between 2004-2008 for men aged 15-60  
with 57% of cases managed completely in general practice.  Notably, only 3% of men under 35 
years were chlamydia tested.(10) 
So, what might contribute to the epididymitis rates observed in this study? Our finding that over 
three-quarters of epididymitis cases in EDs were managed without admission and that different 
age groups experienced higher rates in admissions and ED suggests a different aetiology for 
these settings or differing severity for each aetiology by age group. Admissions data are likely to 
reflect clinically severe epididymitis; potential causes  include chlamydia and gonorrhoea(1), 
uro-pathogens, or enteric pathogens  transmitted via insertive anal intercourse.(2) Recent 
Australian surveillance data show substantial increases in chlamydia and gonorrhoea diagnosis 
for men with same sex and female partners, and, an increasing proportion of gay and bisexual 
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men reporting condomless anal intercourse with casual partners.(3) The latter period of our 
national analysis also coincided with increasing pre-exposure prophylaxis use by non-HIV-
positive men.(3)  These factors could contribute to increases in severe epididymitis requiring 
inpatient management, although the extent is unknown.  
Over three-quarters of epididymitis in EDs were managed without admission. Potentially many 
non-admitted cases were suitable for primary care management. It is possible that factors 
restricting primary care access contributed to our finding of increased ED rates. A chlamydia 
testing intervention in Australian general practice (2010-2015) reported a low epididymitis 
incidence(8) and Australian gay and bisexual men have reported preferences to attend specialist 
rather than mainstream primary care for sexual health care.(11) Limited availability of sexual 
health services or general practice workforce shortages, particularly in non-metropolitan 
areas(12) could limit appointment availability and timely access to general practice thereby 
prompting men with epididymitis to attend ED instead.  
In conclusion, we found increasing epididymitis rates in hospital admissions and EDs, with 
epididymitis managed more frequently in EDs. Different age-related patterns suggest a different 
aetiology in these settings. These results could reflect changing sexual practices, increasing STI 
transmission and/or limited access to general practice, though primary care data are needed to 
better understand health care usage and the epidemiology of male STI-related morbidity.  
 
Legend for figure 1 
Figure 1: A: Hospital admission and emergency department rates of epididymitis per 100,000 
men (in Victoria, NSW and Queensland) by age group, 2009-2014; and, B: Australian admission 
rates of epididymitis per 100,000 men by age group, 2009-2018. 
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